AVP and metabolic dysfunction-associated steatohepatitis: Barchetta et al. examined the relationship between plasma copeptin levels and the presence and severity of MASLD and metabolic dysfunction-associated steatohepatitis (MASH) in 60 individuals with obesity undergoing bariatric surgery.